Intellia Therapeutics

NTLA • NASDAQ

Intellia Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO John Leonard, with a market cap of $1.8B.

Market Cap$1.8B

Employees598.0

CEOJohn Leonard

CountryUnited States of America

Healthcare

Biotechnology

Next EarningsMay 14, 2026 · In 2 weeksBefore Market Open · Q1 2026

Financials

Common questions about Intellia Therapeutics

Intellia Therapeutics is scheduled to report earnings for Q1 2026 on May 14, 2026 before market open. Analysts estimate revenue of $13.6M.

Intellia Therapeutics has approximately 598 employees.